Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: APP Mutations
APPPS1

Updated 5 November 2008

General Information

Transgene: Thy1-APPKM670/671NL and Thy1-PS1L166P constructs were coinjected into male pronuclei of C57BL6J oocytes, integration site on the lower arm of chr 2 between 40 and 60 cM. Generated on a pure C57BL/6J background.

Mutation: coexpresses KM670/671NL mutated amyloid precursor protein and L166P mutated presenilin 1

Promoter: neuron specific Thy 1

Mouse Strain: B6-Tg(Thy1-APPswe; Thy1-PS1 L166P)

Phenotype

Neuropathological Analysis:

APPPS1 develops cerebral amyloidosis at 6-8 weeks, Aβ 42 >> Aβ 40

Behavioral Phenotype:

Cognitive deficits in a 4-arm spatial maze task at 8 months of age

Availability

Contact Dr. Mathias Jucker, University of Tuebingen, mathias.jucker@uni-tuebingen.de

Reference

Primary:

Radde R, Bolmont T, Käser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, Jäggi F, Wolburg H, Gengler S, Haass C, Ghetti B, Czech C, Hölscher C, Mathews PM, Jucker M (2006) Ab42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO reports 7: 940-946. Abstract

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad